Oral colonization by yeasts in HIV-positive patients in Brazil;Colonização oral por leveduras em pacientes HIV-positivos no Brasil

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 54, Issue 1, 2012, Pages 17-24

  Junqueira, Juliana C ^a   Vilela, Simone F G ^a   Rossoni, Rodnei D ^a   Barbosa, Júnia O ^a   Costa, Anna Carolina B P ^a   Rasteiro, Vanessa M C ^a   Suleiman, Jamal M A H ^b   Jorge, Antonio Olavo C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Candida; Colonization; Kodamaea ohmeri; Trichosporon mucoides

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; PHOSPHOLIPASE; PROTEINASE;

ADULT; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BRAZIL; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; FEMALE; FUNGAL COLONIZATION; FUNGUS ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KODAMAEA OHMERI; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUTH CAVITY; NONHUMAN; OROPHARYNX CANDIDIASIS; PICHIA GUILLIERMONDII; PREVALENCE; SALIVA; TRICHOSPORON; TRICHOSPORON MUCOIDES;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, ORAL; FEMALE; FLUCONAZOLE; HIV SEROPOSITIVITY; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PEPTIDE HYDROLASES; PHOSPHOLIPASES;

EID: 84857856193     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652012000100004     Document Type: Article

References (41)

1. Back-Brito GN, Inocêncio ACS, Querido SMR, Jorge AOC, Koga-Ito CY. In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. Braz Oral Res. 2010;25:28-33.
2. Back-Brito GN, Mota AJ, Vasconcellos TC, Querido SM, Jorge AO, Reis AS, et al. Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Mycopathologia. 2009;167:81-7.
3. Badiee P, Alborzi A, Davarpanah MA, Shakiba E. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients. Arch Iran Med. 2010;13:282-7.
4. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. M27-A2. Wayne; 2002.
5. Costa CR, Passos XS, Sousa LK, Lucena AP, Fernandes FO, Silva RM. Differences in exoenzyme production and adherence ability of Candida spp. isolates from catheter, blood and oral cavity. Rev Inst Med Trop Sao Paulo. 2010;52:139-43.
6. D'Eça Júnior A, Silva AF, Rosa FC, Monteiro SG, de Maria Silva Figueiredo P, de Andrade Monteiro C. In vitro differential activity of phospholipases and acid proteinases of clinical isolates of Candida. Rev Soc Bras Med Trop. 2011;44:334-8.
7. Erköse G, Erturan Z. Oral Candida colonization of human immunodeficiency virus infected subjects in Turkey and its relation with viral load and CD4+ T-lymphocyte count. Mycoses. 2007;50:485-90.
8. Gokce G, Cerikcioglu N, Yagci A. Acid proteinase, phospholipase, and biofilm production of Candida species isolated from blood cultures. Mycopathologia. 2007;164:265-9.
9. Gugnani HC, Becker K, Fegeler W, Basu S, Chattopadhya D, Baveja U, et al. Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses. 2003;46:299-306.
10. Jainkittivong A, Lin AL, Johnson DA, Langlais RP, Yeh CK. Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients. Oral Dis. 2009;15:229-34.
11. Jayatilake JA, Samaranayake YH, Samaranayake LP. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J Oral Pathol Med. 2005;34:240-6.
12. Junqueira JC, Colombo CE, Martins JS, Koga-Ito CY, Carvalho YR, Jorge AO. Experimental candidosis and recovery of Candida albicans from the oral cavity of ovariectomized rats. Microbiol Immunol. 2005;49:199-207.
13. Hamza OJ, Matee MI, Moshi MJ, Simon EN, Mugusi F, Mikx FH, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008;8:135.
14. Höfling JF, Mardegan RC, Anibal PC, Furletti VF, Foglio MA. Evaluation of antifungal activity of medicinal plant extracts against oral Candida albicans and proteinases. Mycopathologia. 2011;172:117-24.
15. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50:243-60.
16. Lacasse A, Cleveland KO. Trichosporon mucoides fungemia in a liver transplant recipient: case report and review. Transpl Infect Dis. 2009;11:155-9.
17. Lee JS, Shin JH, Kim MN, Jung SI, Park KH, Cho D, et al. Kodamaea ohmeri isolates from patients in a university hospital: identification, antifungal susceptibility, and pulsed-field gel electrophoresis analysis. J Clin Microbiol. 2007;45:1005-10.
18. Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen. J Dent Res. 2007;86:204-15.
19. Liu H, Miller LG, Hays RD, Golin CE, Zhao H, Wenger NS, et al. A comprehensive evaluation of survey questions for adherence to antiretroviral medications and exploratory analyses for identifying optimal sets of survey questions. AIDS Patient Care STDS. 2006;20:760-72.
20. Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S, Mangaró HM. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina. Mycoses. 2009;52:53-9.
21. Mane A, Pawale C, Gaikwad S, Bembalkar S, Risbud A. Adherence to buccal epithelial cells, enzymatic and hemolytic activities of Candida isolates from HIV-infected individuals. Med Mycol. 2011;49:548-51.
22. Martins JS, Junqueira JC, Faria RL, Santiago NF, Rossoni RD, Colombo CE, et al. Antimicrobial photodynamic therapy in rat experimental candidiasis: evaluation of pathogenicity factors of Candida albicans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:71-7.
23. Melo NR, Taguchi H, Culhari VP, Kamei K, Mikami Y, Smith SN, et al. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies. Med Mycol. 2009;47:149-56.
24. Melo NR, Taguchi H, Jorge J, Pedro RJ, Almeida OP, Fukushima K, et al. Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era. Mem Inst Oswaldo Cruz. 2004;99:425-31.
25. Menon T, Herrera M, Periasamy S, Palanivelu V, Sikhamani R, Wickes B. Oral candidiasis caused by Kodamaea ohmeri in a HIV patient in Chennai, India. Mycoses. 2010;53:458-9.
26. Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11:142-51.
27. Migliorati CA, Birman EG, Cury AE. Oropharyngeal candidiasis in HIV-infected patients under treatment with protease inhibitors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:301-10.
28. Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother. 2002;46:1144-6.
29. PiresGonçalves RH, Miranda ET, Baeza LC, Matsumoto MT, Zaia JE, MendesGiannini MJ. Genetic relatedness of commensal strains of Candida albicans carried in the oral cavity of patients' dental prosthesis users in Brazil. Mycopathologia. 2007;164:255-63.
30. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982;20:7-14.
31. Redding SW, Dahiya MC, Kirkpatrick WR, Coco BJ, Patterson TF, Fothergill AW, et al. Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:47-52.
32. Ribeiro PM, Bacal F, Koga-Ito CY, Junqueira JC, Jorge AOC. Presence of Candida spp. in the oral cavity of heart transplantation patients. J Appl Oral Sci. 2011;19:6-10.
33. Ruchell R, Tegeller R, Trost MA. A comparison of secretory proteinases from different strains of Candida albicans. Sabouraudia. 1982;20:233-44.
34. Sandven P, Nilsen K, Digranes A, Tjade T, Lassen J. Candida norvegensis: a fluconazole-resistant species. Antimicrob Agents Chemother. 1997;41:1375-6.
35. Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of Candida: a mini review. Oral Dis. 2008;14:582-90.
36. Serena C, Mariné M, Pastor FJ, Nolard N, Guarro J. In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula. J Antimicrob. Chemother. 2005;55:1020-3.
37. Shang ST, Lin JC, Ho SJ, Yang YS, Chang FY, Wang NC. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. J Microbiol Immunol Infect. 2010;3:200-6.
38. Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP. Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses. 2009;52:467-75.
39. Thompson GR 3rd, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D, Erlandsen J, et al. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:488-95.
40. Yang YL, Hung CC, Wang AH, Tseng FC, Leaw SN, Tseng YTT, et al. Oropharyngeal colonization of HIV-infected outpatients in Taiwan by yeast pathogens. J Clin Microbiol 2010;48:2609-12.
41. Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, et al. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Diagn Microbiol Infect Dis. 2008;61:175-80.